Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapySEUNG TAE KIM; JI EUN UHM; AHN, Myung-Ju et al.Lung cancer. 2012, Vol 75, Num 1, pp 82-88, issn 0169-5002, 7 p.Article

Analysis of Prognostic Factors of Pediatric-Type Sarcomas in Adult PatientsHEE KYUNG AHN; JI EUN UHM; JOON OH PARK et al.Oncology. 2011, Vol 80, Num 1-2, pp 21-28, issn 0030-2414, 8 p.Article

Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Retrospective Comparison with Previously Known Prognostic ModelsKYUNG KEE BAEK; KIM, Jung-Hoon; JI EUN UHM et al.Oncology. 2011, Vol 80, Num 3-4, pp 167-174, issn 0030-2414, 8 p.Article

A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinomaJI EUN UHM; JOON OH PARK; LEE, Jeeyun et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 5, pp 929-935, issn 0344-5704, 7 p.Article

Prognostic factor analysis in patients with brain metastases from breast cancer : how can we improve the treatment outcomes?PARK, Byeong-Bae; JI EUN UHM; JIN SEOK AHN et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 4, pp 627-633, issn 0344-5704, 7 p.Article

Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapyJI EUN UHM; YEON HEE PARK; WON KI KANG et al.International journal of cancer (Print). 2009, Vol 124, Num 6, pp 1457-1462, issn 0020-7136, 6 p.Article

A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancerHYEONG SU KIM; MIN JAE PARK; WON KI KANG et al.International journal of colorectal disease (Print). 2009, Vol 24, Num 11, pp 1311-1316, issn 0179-1958, 6 p.Article

Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancerMYUNG HEE CHANG; KYOUNG HA KIM; LEE, Jeeyun et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 5, pp 917-924, issn 0344-5704, 8 p.Article

Irinotecan monotherapy as second-line treatment in advanced pancreatic cancerSEONG YOON YI; YOUNG SUK PARK; JOON OH PARK et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 6, pp 1141-1145, issn 0344-5704, 5 p.Article